drugset / Trial / NCT03948464
Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder
Phase 3
Terminated
27 enrolled
M. Eugenia Socias
Canadian Institutes of Health Research (CIHR) · collabMayne Pharma International Pty Ltd · collabVancouver Foundation · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a non-inferiority randomized clinical trial that will compare slow release oral morphine vs methadone as a second line oral treatment for opioid use disorder.
Timeline
- Start
- 2019-12-06
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
Outcome
Outcome not reported
Stopped: “Study unable to proceed per protocol due to COVID-19 precautions”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methadone | Other / unclassified | — | Oral |
| Subject | Morphine | Other / unclassified | — | Oral |